龍蟒佰利(002601.SZ):副董事長譚瑞清已減持1809.03萬股
格隆匯6月30日丨龍蟒佰利(002601.SZ)公佈,2021年6月30日,公司收到副董事長譚瑞清、監事會主席馮軍出具的《股份減持進展情況吿知書》,截至2021年6月30日,上述股東披露的前述股份減持計劃時間區間已過半,馮軍決定提前終止此次減持計劃。
馮軍計劃通過集中競價方式減持不超過36.205萬股公司股份,截至目前尚未實施,仍持有公司股份144.82萬股,佔公司總股本的0.06%。馮軍根據自身資金需求情況及對公司未來發展的信心,決定提前終止此次減持計劃。
譚瑞清計劃通過集中競價交易、大宗交易的方式減持不超過5000萬股公司股份,截至目前已減持1809.03萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.